In humans, benign tumours are likely to be estrogen receptor (ER)-positive with a better prognosis (Maynard et al., 1978), whereas ER-negative tumours are more likely to be of higher histological grade (Parl et al., 1984; Putti et al., 2004). The gene discussed is ESR1; the disease is neoplasm.